Nature 302 , 716718 (1983)
The first time you use a vial, be sure to remove this to expose the rubber stopper
Tirzepatide: The First GLP-1/GIP Dual Agonist Tirzepatide is a dual incretin agonist that activates both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors and was developed to enhance metabolic and weight-loss outcomes beyond those achieved with GLP-1 receptor agonists alone
Potential side effects can vary by product, so always speak to a health care provider with any questions
Ozempic, Wegovy, and Rybelsus are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound and Mounjaro are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC
J Surg Res 2013;185:825-32.ArticlePubMed 13